Physician profile
Jon T Vu
NPI 1730369307
$9,095.30
in general payments reported to CMS, 2019-2025
56 companies · $823 in 2025
The $823 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,977 · 2020: $844 · 2021: $1,586 · 2022: $750 · 2023: $1,019 · 2024: $1,095 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,937.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,008.76 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $1,455.42 | 2019-2025 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $472.65 | 2019-2025 | Relistor |
| Daiichi Sankyo INC. | $470.87 | 2019 | |
| Pacira Therapeutics, INC. | $454.32 | 2019-2020 | |
| Forte Bio-Pharma LLC | $444.17 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Abbott Laboratories | $411.54 | 2019-2025 | Proclaim, Eterna |
| Si-Bone, INC. | $275.47 | 2022-2025 | |
| Medtronic, INC. | $241.84 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Venaseal |
| Abbvie INC. | $222.84 | 2021-2024 | Botox, Qulipta, Ubrelvy |
| Biohaven Pharmaceuticals, INC. | $185.18 | 2021 | |
| Arbor Pharmaceuticals, INC. | $171.42 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $158.12 | 2019-2025 | Ztlido |
| Almatica Pharma LLC | $135.21 | 2021 | |
| Biodelivery Sciences International, INC. | $120.94 | 2021 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $111.49 | 2019-2024 | |
| Sentynl Therapeutics, INC. | $108.37 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $102.70 | 2022 | |
| Boston Scientific Corporation | $101.26 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Allergan, INC. | $88.98 | 2020-2022 | |
| Saluda Medical Americas, INC. | $85.03 | 2025 | Evoke |
| Depuy Synthes Sales INC. | $78.40 | 2020-2024 | Monovisc |
| Biotronik Nro, INC. | $76.54 | 2025 | Prospera |
| Zyla Life Sciences, INC. | $72.41 | 2019-2020 | |
| Nalu Medical, INC. | $70.70 | 2025 | Nalu Neurostimulation System |
| Neuronetics, INC. | $64.29 | 2024 | Neurostar Tms Therapy System |
| Valinor Pharma, LLC | $59.31 | 2023-2025 | Movantik |
| Virtus Pharmaceuticals LLC | $58.21 | 2021 | |
| Medtronic Vascular, INC. | $51.58 | 2019-2020 | |
| Redhill Biopharma INC. | $48.38 | 2020 | |
| Azurity Pharmaceuticals, INC. | $46.72 | 2023-2025 | Horizant, Horizant |
| Avanos Medical | $43.34 | 2023-2024 | Coolief* Cooled Radiofrequency |
| Pacira Pharmaceuticals Incorporated | $41.11 | 2023-2024 | Iovera, Zilretta |
| Globus Medical, INC. | $37.10 | 2025 | Senza |
| Bioventus LLC | $34.57 | 2023-2025 | Durolane, Durolane |
| Spinal Simplicity, LLC | $34.48 | 2024-2025 | Ha Minuteman G3-R |
| Novartis Pharmaceuticals Corporation | $33.64 | 2019 | |
| Medtronic USA, INC. | $32.68 | 2019-2020 | |
| Horizon Therapeutics Plc | $32.09 | 2019-2020 | |
| Averitas Pharma INC. | $29.95 | 2025 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $29.77 | 2019 | |
| Assertio Therapeutics, INC. | $25.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $25.12 | 2022-2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $24.48 | 2025 | |
| Fidia Pharma USA INC. | $23.85 | 2023 | Triluron, Hymovis |
| Jazz Pharmaceuticals INC. | $21.97 | 2023 | Epidiolex |
| Siemens Medical Solutions USA, INC. | $21.31 | 2023 | Cios Select |
| Takeda Pharmaceuticals U.S.A., INC. | $20.48 | 2019 | |
| Shionogi INC | $20.41 | 2019 | |
| Curonix LLC | $20.32 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lundbeck LLC | $18.22 | 2025 | Vyepti |
| Mdd US Operations, LLC | $17.35 | 2019 | |
| Stimwave Technologies Incorporated | $14.86 | 2021 | |
| Becton, Dickinson and Company | $14.75 | 2024 | Venclose Maven Catheter |
| Lilly USA, LLC | $12.77 | 2019 | |
| Indivior INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.